search
close_mark

Stef Schutte

Stef Schutte

02 Dec, 2025

With 30+ years in pharma, Stef has led global Regulatory Affairs at Astellas and served as Head of RA-EMEA at Merck (MSD), advancing development, approvals, and compliance across international markets.

Extensive experience in strengthening regulatory operations, accelerating product development pathways, and building high-performing teams.

Cheryl Jessen
Read Now

Other Related Articles

A Strategic Guide to PMS, eAF, ePI, eCTD 4.0. and ESMP
Blog Pharmaceutical

A Strategic Guide to PMS, eAF, ePI, eCTD 4.0. and ESMP

21 May, 2026

Devices Incorporating Tissues or Cells of Animal or Human Origin, or Their Derivatives: Data Expectations Under EU MDR
Blog Medical Devices

Devices Incorporating Tissues or Cells of Animal or Human Origin, or Their Derivatives: Data Expectations Under EU MDR

13 May, 2026

Nitrosamine Control Insights: Clarity and Control in EU Risk Assessment
Blog Pharmaceutical

Nitrosamine Control Insights: Clarity and Control in EU Risk Assessment

07 May, 2026

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?
Blog Medical Devices

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?

29 Apr, 2026

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR
Blog Medical Devices

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR

22 Apr, 2026

MDR Article 117: What It Means — And How We Help You Get Ahead
Blog Medical Devices

MDR Article 117: What It Means — And How We Help You Get Ahead

16 Apr, 2026

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative
Blog Pharmaceutical

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

10 Apr, 2026

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Blog Pharmaceutical

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

View All